financetom
Business
financetom
/
Business
/
Star Entertainment executive chair Foster steps down, adds to management exodus
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Star Entertainment executive chair Foster steps down, adds to management exodus
Apr 28, 2024 4:52 PM

(Reuters) - Star Entertainment said on Monday its Executive Chairman David Foster will leave step down just weeks after being appointed to the role, adding to an exodus of senior management at the beleaguered Australian casino operator.

The management departures come at a time when the casino operator faces a second inquiry into its Sydney casino operations investigating Star's ability to be fit to run the Star Sydney casino or hold a casino licence.

Foster, who became chairman in March 2023, took over additional executive duties late last month after the casino operator's chief executive, Robbie Cooke, and finance officer, Christina Katsibouba, announced their exit.

Earlier this month, Jessica Mellor, chief executive of Star Gold Coast casino in Queensland -- the casino's youngest and first female chief -- announced her departure without providing any reason.

Anne Ward, an independent and non-executive director appointed to the Star board in November 2022, will take over as chair effective immediately.

Star is yet to find a permanent replacement for its chief executive position.

The casino operator is facing a second inquiry into its Sydney operations after a license to operate the casino was suspended in October 2022, with the regulator "not satisfied" with the company's progress on its remedial measures in Sydney.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Corbus Pharma Q3 net loss widens to $23.3 mln
Corbus Pharma Q3 net loss widens to $23.3 mln
Nov 12, 2025
Overview * Corbus Pharmaceuticals ( CRBP ) Q3 net loss widens to $23.3 mln, driven by clinical development costs * Company completed $75 mln public offering, extending cash runway into 2028 * CRB-701 clinical data shows promising ORR in HNSCC, cervical, and bladder cancers Outlook * Company plans to meet FDA in Q1 2026 for CRB-701 data review * Corbus...
Apparel retailer LightInTheBox Q3 net income jumps, revenue drops on margin focus
Apparel retailer LightInTheBox Q3 net income jumps, revenue drops on margin focus
Nov 12, 2025
Overview * LightInTheBox ( LITB ) Q3 net income rises to $2.8 mln from $0.3 mln last year * Company Q3 revenue declines 3% yr/yr, reflecting focus on margin preservation * Gross margin improves to 66.9% from 61.1% last year, driven by high-margin products Outlook * LightInTheBox ( LITB ) expects overall revenue growth in 2026 * Company plans broader...
Coya Therapeutics' Q3 net loss narrows
Coya Therapeutics' Q3 net loss narrows
Nov 12, 2025
Overview * Coya Therapeutics ( COYA ) Q3 net loss narrows to $2.1 mln from $4.0 mln last year * Company reports $3.6 mln collaboration revenue due to IND approval milestone * Coya completes $23 mln public offering, extending cash runway into 2H 2027 Outlook * Company expects to receive $4.2 mln milestone payment upon first patient dosing in ALS...
Cypherpunk Technologies' Q3 net loss narrows
Cypherpunk Technologies' Q3 net loss narrows
Nov 12, 2025
Overview * Cypherpunk Technologies reports Q3 net loss of $3.3 mln, down from $18.2 mln last year * Company acquires 203,775 ZEC for $50 mln as part of digital asset strategy * Closed $58.88 mln private placement led by Winklevoss Capital for digital asset strategy Outlook * Company did not provide specific financial guidance for future quarters or year Result...
Copyright 2023-2025 - www.financetom.com All Rights Reserved